Myomo Inc announces additional intellectual property protection with the issuance of new patents in the US and Europe related to MyoPro, its wearable robotic brace designed for those with arm and hand paralysis.
The U.S. Patent and Trademark Office has notified the Company that
Patent No. 10,758,394 from the U.S. Patent and Trademark Office, issued September 1, 2020, is titled “Powered Orthotic Device and Method of Using Same” and extends the patent life on most MyoPro models through March 2039 as the protected technology now covers the use of the device for multiple joints, including a hand actuator.
Issuance is pending on a new parallel patent covering the European Patent Office’s 38 member countries.
With these recent patent grants, the Company now has 12 patents issued worldwide, two exclusive licensed patents and nine patents pending relating to MyoPro, according to the company in a news release.
“We are very proud of the ingenuity and technical skills of our engineering team, as demonstrated by receipt of these patents. Their hard work is displayed every day by the hundreds of patients whose lives have been improved by MyoPro.”
— Gene Tacy, Myomo’s Vice President of Engineering and Manufacturing
“This expansion of our global patent position solidifies our leadership as the world’s only supplier of a myoelectric powered upper limb orthosis. We are committed to protecting our intellectual property around the world in order to secure the long-term value of the MyoPro.”
— Paul R. Gudonis, Myomo’s chief executive officer
[Source(s): Myomo Inc, Business Wire]